INVARIANT LLC for CIGNA CORPORATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Inform policymakers on issues related to H.R. 6833/S. 3700, the Affordable Insulin Now Act and related issues; issues realted to FY 2023 Appropriations, including telehealth, mental health, and health care affordability; issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; issues related to H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022; issues related to S. 4293, the Pharmacy Benefit Manager Transparency Act of 2022; and P.L. 117-169, the Inflation Reduction Act of 2022, including Enhanced advance premium tax credits (APTCs) and Medicare Part D redesign.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| ANNABELL MCWHERTER STOKES | — |
| KATHRYN WISE | — |
Medicare/Medicaid MMM
Inform policymaker on issues related to H.R. 3173/S. 3018, the Improving Seniors' Timely Access to Care Act of 2021; H.R. 3554/S. 1909, the Pharmacy DIR Reform To Reduce Senior Drug Cost Act; and issues related to Pharmacy Direct and Indirect Remuneration (DIR), including Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| ANNABELL MCWHERTER STOKES | — |
| KATHRYN WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.